• 1
    Anonymous. Organ Procurement and Transplant Network-HRSA. Final rule with comment period. Federal Register 1998; 63:1629616338.
  • 2
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing intrahepatic portosystemic shunts. Hepatology 2000; 31:864871.
  • 3
    Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464470.
  • 4
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesopageal varices. Br J Surg 1973; 60:646649.
  • 5
    Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001; 7:567580.
  • 6
    Freeman RB, Rohrer RJ, Katz E, Lewis WD, Jenkins R, Cosimi AB, et al. Preliminary results of a liver allocation plan using a continous medical severity score that de-emphasis waiting time. Liver Transpl 2001; 7:173178.
  • 7
    Guardiola J, Xiol X, Escriba JM, Castellvi JM, Castellote J, Baliellas C, et al. Prognosis assessment of cirrhotic patients with refractory ascites treated with peritoneovenous shunt. Am J Gastroenterol 1995; 90:20972102.
  • 8
    Institute of Medicine. Analysis of waiting times. In: Committee on Organ Procurement and Transplantation Policy, ed. Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule. Washington, DC: National Academy Press; 1999:5778.
  • 9
    Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: An evolution from Child to MELD. Hepatology 2001; 33:473475.